Elanco Animal Health Inc (ELAN)
17.00
-0.19
(-1.11%)
USD |
NYSE |
May 20, 16:00
17.00
0.00 (0.00%)
Pre-Market: 20:00
Elanco Animal Health Enterprise Value: 13.82B for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 13.82B |
| May 17, 2024 | 13.91B |
| May 16, 2024 | 13.81B |
| May 15, 2024 | 13.84B |
| May 14, 2024 | 13.86B |
| May 13, 2024 | 13.82B |
| May 10, 2024 | 13.82B |
| May 09, 2024 | 13.92B |
| May 08, 2024 | 13.77B |
| May 07, 2024 | 12.10B |
| May 06, 2024 | 11.97B |
| May 03, 2024 | 12.11B |
| May 02, 2024 | 12.08B |
| May 01, 2024 | 11.92B |
| April 30, 2024 | 11.92B |
| April 29, 2024 | 12.12B |
| April 26, 2024 | 11.97B |
| April 25, 2024 | 11.86B |
| April 24, 2024 | 12.00B |
| April 23, 2024 | 12.07B |
| April 22, 2024 | 11.81B |
| April 19, 2024 | 11.82B |
| April 18, 2024 | 12.12B |
| April 17, 2024 | 12.05B |
| April 16, 2024 | 12.16B |
| Date | Value |
|---|---|
| April 15, 2024 | 12.27B |
| April 12, 2024 | 12.51B |
| April 11, 2024 | 12.71B |
| April 10, 2024 | 12.71B |
| April 09, 2024 | 12.96B |
| April 08, 2024 | 13.07B |
| April 05, 2024 | 13.11B |
| April 04, 2024 | 13.07B |
| April 03, 2024 | 13.04B |
| April 02, 2024 | 13.12B |
| April 01, 2024 | 13.31B |
| March 31, 2024 | 13.46B |
| March 28, 2024 | 13.45B |
| March 27, 2024 | 13.39B |
| March 26, 2024 | 13.26B |
| March 25, 2024 | 13.27B |
| March 22, 2024 | 13.22B |
| March 21, 2024 | 13.46B |
| March 20, 2024 | 13.40B |
| March 19, 2024 | 13.15B |
| March 18, 2024 | 13.20B |
| March 15, 2024 | 13.17B |
| March 14, 2024 | 13.19B |
| March 13, 2024 | 13.27B |
| March 12, 2024 | 13.20B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.410B
Minimum
May 21 2020
22.89B
Maximum
Aug 03 2021
14.70B
Average
13.22B
Median
Enterprise Value Benchmarks
| Zoetis Inc | 84.18B |
| Dynavax Technologies Corp | 990.30M |
| Geron Corp | 1.852B |
| Esperion Therapeutics Inc | 505.29M |
| Krystal Biotech Inc | 4.158B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 32.00M |
| Revenue (Quarterly) | 1.205B |
| Total Expenses (Quarterly) | 1.072B |
| EPS Diluted (Quarterly) | 0.06 |
| Gross Profit Margin (Quarterly) | 57.26% |
| Profit Margin (Quarterly) | 2.66% |
| Earnings Yield | -15.59% |
| Operating Earnings Yield | 2.84% |
| Normalized Earnings Yield | -1.985 |